The 25th Bangkok International Symposium on HIV Medicine-Reference-Cited by-同舟云学术

The 25th Bangkok International Symposium on HIV Medicine

Published:2023-03 Issue:4 Volume:18 Page:209-213
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Ohata Pirapon June¹^ORCID,Avihingsanon Anchalee¹²^ORCID,Thammapiwan Siwat¹,Han Win Min¹²^ORCID,Hiransuthikul Akarin³^ORCID,Su Lwin Hay Mar¹,Ubolyam Sasiwimol¹²^ORCID,Boonrungsirisap Jedsadakorn¹,Kerr Stephen J¹⁴⁵^ORCID,Gatechompol Sivaporn¹²^ORCID,Puthanakit Thanyawee⁶^ORCID,Putcharoen Opass⁷^ORCID,Ruxrungtham Kiat⁸^ORCID,Phanuphak Praphan¹^ORCID

Affiliation:

1. HIV-NAT, Thai Red Cross – AIDS Research Centre, 104 Ratchadamri Rd., Pathumwan, Bangkok, 10330, Thailand

2. Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand

3. Department of Preventive & Social Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand

4. Biostatistics Excellence Centre, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd, Pathumwan, Bangkok, 10330, Thailand

5. The Kirby Institute, University of New South Wales, NSW, Sydney, 2052, Australia

6. Department of Pediatrics, Division of Pediatric Infectious Diseases, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 9th Floor, Sor Kor Building, Rama 4 Road, Patumwan, Bangkok, 10330, Thailand

7. Department of Medicine, Division of Infectious Disease, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand

8. Chula Vaccine Research Center (ChulaVRC) Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand

Abstract

Proceedings of: 25th Bangkok International Symposium on HIV Medicine, 18–20 January 2023, held virtually and on site at Samyan Mitrtown Hall, Bangkok, Thailand. The Bangkok International Symposium on HIV Medicine has commenced on the third Wednesday of January since 1998. The Symposium aims to provide professional healthcare workers in Thailand and the region an opportunity to receive the most up-to-date information on HIV and its related conditions if they are unable to attend other HIV conferences abroad. This year’s hybrid symposium was held from 18 January to 20 January 2023. A total of six plenary sessions were held in the mornings, and four afternoon workshops held on Wednesday and Thursday. Expert speakers from Thailand, China, Malaysia, Singapore, India, Hong Kong, the Philippines, Australia, the UK, The Netherlands and the USA participated in the symposium.

Funder

ViiV GSK

Gilead and DCH Auriga

Oxford Immunotec Limited

amfAR/TREAT Asia

Atlanta

Camber Pharmaceuticals

Cepheid

Sysmex Asia Pacific Pte Ltd

Abbott

The Government Pharmaceutical Organization

UNSW Kirby Institute

Thailand Convention and Exhibition Bureau

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2023-0019

Reference18 articles.

1. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

2. Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

3. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

4. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance

5. World Health Organization. Post COVID-19 condition (long COVID) (2022). www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:∼:text=Definition,months%20with%20no%20other%20explanation